Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STSP-0601 in hemophilia with inhibitors
CTR20211762Phase 2Completed
- Sponsor
- Staidson Biopharmaceutical
- Start
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of bemiltenase alfa in hemophilia A, hemophilia B (HB), sponsored by Staidson Biopharmaceutical. Started Jul 2021; status: completed.
02
Drugs
bemiltenase alfa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on CTR20211762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211762.